iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.430
-0.040 (-2.72%)
Aug 21, 2026, 4:00 PM EDT - Market closed
iBio, Inc. Market Cap
iBio, Inc. has a market cap or net worth of $71.04 million as of August 21, 2026. Its market cap has increased by 375.77% in one year.
Market Cap
71.04M
Enterprise Value
-1.43M
1-Year Change
375.77%
Ranking
Category
Stock Price
$1.43
ChartMarket Cap Chart
Since August 19, 2008, iBio, Inc.'s market cap has increased from $14.01M to $71.04M, an increase of 406.98%. That is a compound annual growth rate of 9.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 71.04M | 63.69% |
| Dec 31, 2025 | 43.40M | 93.61% |
| Dec 31, 2024 | 22.42M | 716.05% |
| Dec 29, 2023 | 2.75M | -41.32% |
| Dec 30, 2022 | 4.68M | -96.09% |
| Dec 31, 2021 | 119.66M | -46.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Serina Therapeutics | 72.90M |
| LeonaBio | 72.19M |
| Pliant Therapeutics | 71.52M |
| PMV Pharmaceuticals | 71.10M |
| Spero Therapeutics | 71.05M |
| OS Therapies | 70.82M |
| Rein Therapeutics | 70.57M |
| XBiotech | 69.51M |